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Introduction 1 2
Adult diabetes is a metabolic disease characterized by defects in insulin 3 production and utilization. Millions of people are diagnosed with Type II diabetes 4 worldwide, and the numbers of those afflicted are predicted to steadily increase 1 . 5
Progression of Type II diabetes involves the interplay between insulin and blood 6 glucose levels, with initial disease stages characterized by insulin resistance and 7 hyperinsulinemia 2 . In more advanced stages of Type II diabetes, insulin secretory ability 8 becomes further compromised and results in hyperglycemia 3 . The net result is a 9 dysfunction in carbohydrate homeostasis. The fruit fly Drosophila melanogaster has proven to be a useful model to study 21 questions related to insulin/IGF effects on growth and metabolism 9,10 . One function of 22 the insulin/IGF and TOR systems in Drosophila is to assess the nutritional status of the 23 8
To mark IPCs, we used either UAS-mCD8::mRFP or UAS-DsRed.nls. The former 1 expresses a mouse CD8 transmembrane domain fused to the N-terminus of mRFP 38 . 2
The latter expresses dsRed with a nuclear localization tag at the C-terminus 39 . 3
To determine whether miR-7 RNA is expressed in IPCs, we used a mir-7 4 transcriptional enhancer driving GFP 40 . This consists of a 349 bp region upstream of the 5 mir-7 transcription start site. The mir-7 enhancer region was placed upstream of a 6 minimal promoter (TATA) and sequence encoding for a nuclear localized GFP was 7 placed downstream of this region. The mir-7 enhancer contains two binding sites for the 8 bHLH factor Atonal, which was previously demonstrated to regulate enhancer activity in 9 the eye 40 . To determine if bHLH factors regulate of enhancer activity in IPCs, we used 10 animals that expressed GFP under the control of the mir-7 enhancer, but with the two 11 bHLH binding sites mutated 40 . 12
To assay miR-7 silencing activity in IPCs, we utilized miRNA silencing sensors. 13
The miR-7 sensor expresses GFP under the control of the tubulin promoter and with a 14 3'UTR that contains two perfectly complementary miR-7 binding sites 41 . The control 15 sensor drives GFP under the control of the same tubulin promoter, however there are 16 no miR-7 binding sites in the 3'UTR 41 . 17
To quantify stored and circulating dILP2 levels, we used flies expressing 18 dILP2HF 25 . These flies are null mutant for the endogenous dILP2 gene, but express a 19 genomic dILP2 transgene that has been tagged with an HA epitope at the B-chain 20 carboxy terminus and a FLAG epitope at the A-chain amino terminus. 21
To identify miR-7 regulatory targets, RNAi lines were obtained from Bloomington 22 Drosophila Stock Resource Center or from the Vienna Drosophila Resource Center. 23 9 Each RNAi line has a UAS promoter that drives a double-stranded hairpin RNA 1 corresponding to an annotated Drosophila gene 42 . Each line was crossed to dILP2-Gal4 2 animals, and progeny bearing both transgenes were assayed. 3 4
Body Weight Measurement 5
All Drosophila to be weighed were raised at 25°C. Adult females were weighed no more 6 than 24 hours after eclosion, and batches of 20-50 animals were counted and weighed 7 on a Mettler analytical balance. Larvae undergoing the pupal molt were identified as 8 "white prepupae", and batches of these animals were counted and weighed as 9 described. Mean weight was estimated for each replicate batch, and multiple replicates 10 were assayed for both adult and larval experiments. For all weighing experiments, 11 wildtype controls were animals with one copy of the dILP2-Gal4 gene located on either 12 the second or third chromosome. The insertion site of the dILP2-Gal4 gene in control 13 lines was matched to its mir-7 perturbation since we found that different insertion lines 14 caused animals to vary in weight. The cause might be linked to Gal4 itself mildly 15 affecting IPC function 16 17
Adult Wing Measurement 18
Length of the adult wing scales proportionally with total size of adult Drosophila. To 19 measure wing length, wings from 3-5 day old adult male flies were preserved in 70% 20
(v/v) ethanol. Preserved wings were mounted in 70% (v/v) glycerol and imaged using a 21
Zeiss Axiophot microscope and a 4x objective. Images were digitized using the Zeiss 22
Zen imaging software. To measure wing blade length, the distance between the anterior 1 crossvein and wing margin (point where it intersects with the L3 longitudinal vein) was 2 measured using the Microruler package in ImageJ software. 3 4
Metabolite Measurements 5
Triglycerides -To determine total body triglycerides, five wandering third instar larvae 6 were homogenized in freshly made phosphate buffered saline (PBS) + 0.05% (v/v) 7
Tween-20 (Sigma). . Homogenate was heated to 70°C, centrifuged at 3000 x g, and 8
then at 3500 x g. Following centrifugation, 25 μl supernatant was added to 100 μl Infinity 9
Triglycerides Reagent (Thermo Scientific) and incubated at 37°C for 10 minutes (min). 10
Absorbance at 540 nm was measured to determine total triglycerides. Following 11 triglyceride measurements, total protein was determined by the Bradford assay. 12
13
To determine levels of circulating triglycerides, hemolymph was extracted from 14 wandering third instar larvae as described 43 and diluted 1:10 in PBS. Samples were 15 heated at 70°C for 5 min and then centrifuged for 10 min at 16000 x g. Five μl 16 supernatant was added to 100 ul Infinity triglyceride reagent, and samples were 17 incubated at 37°C for 10min. Absorbance at 540 nm was measured using a Biotek 18
Synergy 4 microplate reader. 19
Glucose -To measure circulating glucose levels, porcine kidney trehalase (Sigma) 20 was diluted 1:1000 (v/v) in Infinity Glucose Reagent (Thermo Scientific), and pH was 21 adjusted to 6.5 with HCl. One μl of hemolymph was extracted from wandering third 22 instar larvae and added to 100 μl Glucose Reagent supplemented with trehalase, and 23 samples were incubated overnight at 37°C. Absorbance at 340 nm was measured using 1 the Biotek Synergy4 microplate reader. 2 3 ELISA assay of brain and circulating dILP2HF 4
To measure circulating dILP2HF levels, 2.5 μg/ml anti-FLAG antibody (Sigma-Aldrich 5 F1804) in 0.2 M sodium bicarbonate pH 9.4 buffer was incubated overnight in wells of 6 an ELISA plate (Nunc Immuno Module, Thermo Scientific 468667). Following two 7 washing steps, wells were blocked overnight in PBS + 2% (w/v) BSA (Sigma). Three μl 8 of hemolymph was extracted from male wandering third instar larvae and added to 37 μl 9 PBS. Hemolymph samples were centrifuged at 16000 x g for 5 min. 35 μl of supernatant 10 was added to 5 μl PBS + 2% (v/v) Tween-20 supplemented with anti-HA-antibody 11 conjugated to horseradish peroxidase (Roche) (1:500 v/v dilution from stock). This was 12 added to one well of a blocked ELISA plate, and incubated overnight at 4°C. Wells were 13 washed with PBS+ 0.2% (v/v) Tween-20 and developed using 100 μl One Step Ultra 14 TMB -ELISA Substrate (Thermo Scientific) for 30 minutes at room temperature. 15
Reactions were stopped with 100 μl 2 M sulfuric acid, and absorbance was measured at 16 450 nm. 17
18
To measure stored brain dILP2HF levels, three brains were dissected from 19 wandering third instar larvae and homogenized in 150 μl PBS + 1% (v/v) Triton-X100. 20
Samples were vortexed for 5 min and then centrifuged at 16000 x g for 5 min. 35 μl 21 supernatant was used to perform the ELISA assay, as described above. Total brain 22 protein levels were determined by Bradford assay. 23 1
Tissue preparation and imaging 2
Brains of male wandering third instar larvae were dissected and fixed for 60 min at room 3 temperature in 4% (w/v) paraformaldehye (Sigma) in PBS. Washes were performed 4 using PBS. Brain tissue was mounted in Vectashield and images were collected using a 5
Leica SP5 laser scanning confocal microscope. Fluorophores were excited sequentially 6 using the 488 and 561 laser lines. When comparing conditions, samples were imaged 7 side by side on the same slide, using identical parameters between conditions. Images 8 were collected as Z-stacks, with optical section thickness set to 2.98 μm for miR-7 9 sensor and reporter images, while images of the miR-7 sponge had an optical section 10 thickness of 2.52 μm. Imaging was performed with the 40X oil objective lens, with 1.25 11 NA, and 1024 x 1024 resolution. All scans were done with the bidirectional scanner, and 12 line averaging was set to 6x. Offset was set to zero, and gain was adjusted to minimize 13 overexposure of the brightest sections. 14 15 16
RNA extraction and RT-qPCR 17
Seven to ten brains from male wandering third instar larvae were dissected in PBS and 18 homogenized in 200 μl TRIzol Reagent (Invitrogen). RNA was extracted according to 19 the manufacturer's instructions. SuperScript III reverse transcriptase (Thermo) was 20 used for reverse transcription of RNA. The reaction was primed using oligo-dT and 21 random 9mer primers (2:1 molar ratio). 25 ng cDNA was used as a template for each 22 qPCR reaction using SyBr Green. Gene mRNA levels were normalized to β-tubulin 1 mRNA level using the standard delta-delta Ct method. The algorithms PicTar, Sloan-Kettering, PITA, MiRTE, miRanda, and TargetScan were 5 used to predict miR-7 targets in annotated Drosophila melanogaster genes 40 . For 6 prediction of miR-7 targets in annotated human genes, PicTar, TargetScan, and PITA 7 were used 40 . Genes predicted by three or more algorithms for Drosophila, and two or 8 more algorithms for humans were considered to be predicted targets. Human orthologs 9
of Drosophila predicted targets were determined using Ensembl, InParanoid, and binding site in the cpa 3'UTR was mutated singly or together to generate three different 19 mutant reporters. Site 1 (2R:21059118-21059126) was mutated from GTCTTCCA to 20 GCTCCCCA. Site 2 (2R:21059595-21059601) was mutated from GTCTTT to 21
GTGGGG. 22
To perform luciferase assays, Drosophila S2 cells were cultured in Schneider's 1 media supplemented with 10% FBS and seeded at a density of 2x10 6 cells per ml prior 2 to transfection. Cells were co-transfected with pMT-Ren, which is a control reporter for 3
Renilla luciferase 44 , and pMT-GL3 containing either a wildtype or mutant cpa 3'UTR. 4
These were transfected at a 1:10 molar ratio, respectively, Cells were also transfected 5 with pUAS-miR-7 and Ubiquitin-Gal4 plasmids. Transfections were performed with 6
Effectene Transfection Reagent (Qiagen) according to manufacturer's protocol. To 7 induce reporter expression, Cu2SO4 was added to 0.5 mM final concentration. Twenty 8 four hours after induction, cells were lysed, and luciferase assays were performed using 9
the Dual Luciferase Assay system (Promega). Luciferase activities were quantified 10 using the Glomax Luminometer, and Firefly luciferase activity was normalized as the 11 ratio of Firefly to Renilla enzymatic activities per sample. However, it is unclear whether miR-7 is expressed in the IPCs of Drosophila. In order to 21 answer this question, we examined a transgenic reporter gene for miR-7 expression. 22
This transgene has the transcriptional enhancer of the mir-7 gene fused to a minimal 23 promoter driving transcription of GFP. The reporter faithfully reproduces the expression 1 pattern of miR-7 in various tissues of the fly 40 . The transgene showed broad expression 2 in the larval brain, as evident by nuclear-localized GFP fluorescence. To mark the 3 location of the IPCs, we expressed membrane-bound RFP specifically in IPCs using the 4 dILP2 gene promoter to drive expression. The IPCs occupy a stereotyped position in 5 the larval brain with 14 cells residing on the left and right hemispheres of the brain (Fig.  6 1B). The IPCs could clearly be identified with the membrane RFP marker (Fig. 1C ), and 7
all IPCs were labeled with nuclear GFP, suggesting that the mir-7 enhancer is active in 8 IPCs (Fig. 1C ). To further validate our conclusion, we examined GFP expression from a 9
reporter gene in which two binding sites for bHLH transcription factors were mutated in 10 the enhancer. These binding sites are essential for mir-7 expression in other tissues of 11 Drosophila 40 . The mutant enhancer was completely inactive in the larval IPCs ( Fig. 1D) . 12
Thus, the Drosophila mir-7 gene requires bHLH factors to augment mir-7 expression in 13
IPCs. This is comparable to the requirement of the bHLH factor NeuroD/Beta2 for mir-7 14 transcription in mouse β-cells 32 . 15
16
To demonstrate that miR-7 RNA is functionally active in IPCs, we used a 17 transgenic sensor for miR-7 silencing activity 41 . Transgenic mRNA is transcribed 18 ubiquitously in all cells, and it contains two perfect binding sites for miR-7. If miR-7 is 19 loaded into miRISC, it inhibits the synthesis of the GFP protein product of the transgene 20 in that cell. Thus, reduction of GFP fluorescence is an indicator of miR-7 silencing 21 activity. The miR-7 sensor showed weak GFP expression in larval IPCs (Fig. 1E ). As a 22 control, a transgene sensor lacking miR-7 binding sites was also examined for GFP 23 expression in IPCs. As expected, the control sensor gave strong ubiquitous GFP 1 expression in larval IPCs (Fig. 1E ). Thus, miR-7 is not only expressed but is functionally 2 active in the IPCs of growing Drosophila. 3 4 5
IPC-specific miR-7 regulates body weight and metabolite levels 6 7
Growth in Drosophila is facilitated by the IPCs in the larval brain. Ablation of 8 larval IPCs results in smaller adults 9 . IPC ablation can be engineered by expressing the 9 pro-apoptotic gene Reaper in IPCs using dILP2-Gal4. We wondered if miR-7 plays a 10 role in IPC regulation of growth. Therefore, we made gain-of-function and loss-of-11 function perturbations of miR-7 specific to IPCs and not to other cells of the body. We 12 reasoned that since miR-7 is expressed in many tissues 40 , classical mir-7 mutations 13 might produce confounding effects not directly related to IPC function. We 14 overexpressed miR-7 specifically in IPCs by combining dILP2-Gal4 and UAS-mir-7 15 transgenes in animals. Since Gal4 is only present in IPCs due to the dILP2 gene 16 promoter, miR-7 is only overexpressed in these cells. We weighed such animals when 17 they reached adulthood, and observed a decrease in mean body weight compared to 18 wildtype siblings ( Fig. 2A) . We compared the effects of miR-7 overexpression with IPC 19 cell ablation by Reaper. The effect of miR-7 overexpression on adult body weight was 20 slightly less potent than the effect of IPC ablation on body weight ( Fig. 2A) . 21
IPCs primarily regulate adult body size by affecting the growth rate during the 22 juvenile phase of the life cycle 9 . To determine whether miR-7 regulates larval growth, 23
we weighed animals at the larval-to-pupal molt. As observed in adults, miR-7 1 overexpression caused a decrease in body size at this stage ( Fig. 2B) . 2
To generate a loss-of-function perturbation, we inhibited miR-7 by 3 overexpressing a miR-7 sponge RNA specifically in IPCs. Sponge RNAs contain 4 partially complementary binding sites to a miRNA of interest, and are produced from 5 transgenes within cells 37 . When overexpressed, sponge RNAs sequester the miRNA of 6 interest and titrate it away from its natural targets. The UAS-miR-7 sponge transgene 7 expresses mRNA with ten tandem copies of a sequence complementary to miR-7 8 inserted in the 3' UTR 37 . To confirm the potency of the miR-7 sponge, we co-expressed 9 the sponge along with UAS-mir-7 in IPCs using dILP2-Gal4. This largely neutralized the 10 effect of miR-7 overexpression on body weight (Fig. 2C ). When we expressed just the 11 miR-7 sponge alone in IPCs, there was a small but significant increase in body weight 12 of animals at the larval-to-pupal molt ( If so, we predicted that mir-7 mutants would display an abnormal number or morphology 16 of IPCs. However, null mir-7 mutants and mir-7 overexpression mutants had the normal 17 number and arrangement of IPCs (Fig. 2D) . Growth is controlled by the balanced utilization and storage of carbohydrates and 19 lipids. Impaired insulin signaling in diabetic patients is characterized by fasting 20 hyperglycemia. Late third instar Drosophila larvae undergo cycles of feeding and fasting 21 as they prepare for the pupal molt. Fasting animals can be easily identified by their clear 22 digestive systems when given colored food. We extracted hemolymph from fasting late 1 third instar larvae and measured their circulating sugar levels. Insects have two types of 2 carbohydrates in circulation: glucose and trehalose. Glucose is obtained from food 3 sources, while trehalose (the disaccharide of glucose) originates from the fat body, and 4 is the primary sugar consumed by cells. Although knockdown of miR-7 in IPCs did not 5 have a significant effect on circulating sugar levels, overexpression of miR-7 in IPCs 6 caused an increase in circulating sugars (Fig. 3A) . Inhibition of dILP expression or 7 ablation of IPCs generate similar effects on circulating sugars 9,11 . 8
The storage of fat in insects is primarily in the form of triglycerides. The ratio of 9 body triglyceride to protein is a measure of relative fat storage in Drosophila. We 10 compared this ratio between miR-7 overexpressing and wildtype larvae. There was a 11 significant increase in normalized triglycerides when miR-7 was overexpressed in IPCs 12 ( Fig. 3B ). This phenotype is also observed when adults lack any IPCs 47 . Conversely, 13 expression of miR-7 sponge RNA in IPCs caused a decrease in total triglycerides (Fig.  14   3B) . These effects were exerted on non-circulating triglycerides since there was little or 15 no difference in circulating triglyceride levels in the different genotypes ( Fig. 3C ). Thus, 16 the resulting product is normally processed, secreted, and fully functional 25 . This 6 dILP2HF transgene enabled us to monitor both mRNA and peptide expressed from the 7
IPCs. First, we asked whether dILP2HF mRNA expression changed as a result of miR-7 8 perturbation. dILP2HF mRNA abundance was measured in whole brains of late third 9 instar larvae by RT-qPCR. Sponge-mediated knockdown of miR-7 resulted in an 10 increase in dILP2HF mRNA levels (Fig. 4A) . Conversely, overexpression of miR-7 11 decreased dILP2HF mRNA abundance by three-fold ( Fig. 4A) . Thus, miR-7 represses 12 dILP2 mRNA levels. 13
14
To determine if these effects were also exerted at the peptide level, we 15 performed an ELISA assay, which can accurately measure dILP2HF peptide ranging 16 from 40 attomoles to 4 femtomoles 25 . We observed a two-fold increase in dILP2HF 17 peptide within the brain when miR-7 was knocked down by the sponge (Fig. 4B) , 18 consistent with effects on mRNA levels. Surprisingly, we saw that dILP2HF peptide level 19 within the brain also increased when miR-7 was overexpressed in IPCs, even though 20 mRNA levels decreased (Fig. 4A,B) . Therefore, we measured the levels of dILP2HF 21 peptide in circulation. Knocking down miR-7 in IPCs elevated circulating dILP2HF levels 22 consistent with its effects on brain dILP2HF (Fig. 4C) . Strikingly, miR-7 overexpression 23 decreased the levels of circulating dILP2HF (Fig. 4C) . Thus, when miR-7 was 1 overexpressed in IPCs, stored brain dILP2HF rose but circulating levels dropped. This 2 suggested that miR-7 might inhibit the release of dILP2HF from IPCs, thereby 3 accounting for a buildup of stored dILP2HF and a drop of dILP2HF in circulation. 4
5
Our results suggest that miR-7 inhibits body growth, and miR-7 also inhibits 6 dILP2 synthesis and release from IPCs. We wondered if the effect of miR-7 on dILP2 7
was responsible for its effect on growth. To test this idea, we overexpressed dILP2 in 8
IPCs that also overexpressed miR-7 (Fig. 4D ). The body weight of such individuals was 9 partially rescued from the miR-7 effect. Thus, dILP2 at least partly mediates the effect of 10 miR-7 on growth. One possible explanation for the partial rescue is that dILP2 11 overexpression does not necessarily alleviate the impact miR-7 has on dILP2 release 12 from the IPCs. mRNAs. The primary recognition sequence is a 7 -8 nucleotide "seed" that anneals to 18 the 5' end of a miRNA 48 . To identify mRNAs that are directly regulated by miR-7, we 19 used computational prediction based on the presence of conserved seed sequences in 20 annotated mRNAs. Different algorithms use different criteria when predicting the 21 interaction between a miRNA and its mRNA target. To reduce the risk of identifying 22 false positives, five different target prediction algorithms were used in parallel. We 23 initially asked whether any algorithm predicted that miR-7 directly represses dILP2 1 expression by base-pairing to dILP2 mRNA. Our rationale was that since miR-7 inhibits 2 dILP2HF mRNA expression, it might do so directly. However, none of the algorithms 3 predicted miR-7 binding sites in the 3'UTR of the dILP2, 3 and 5 genes (data not 4 shown). 5 6 Predicted target genes were prioritized by considering those genes identified by 7 three or more different algorithms. A total of 97 genes were identified that fulfilled this 8 criterion. We next performed an experimental screen of these genes to determine if any 9 of them might regulate IPC function. If a target gene directly mediates the effect of miR-10 7 on growth control by IPCs, we reasoned that RNAi knockdown of the gene specifically 11
in IPCs would resemble miR-7 overexpression. The simplest phenotypic readout of 12 growth control is adult body size, and miR-7 overexpression causes adults to weigh less 13 than normal ( Fig. 2A) . Adult body size scales proportionally with wing blade length: the 14 distance between points where the third longitudinal vein intersects the wing margin and 15 anterior crossvein (Fig. 5A) 49 . miR-7 overexpression in IPCs reduced wing blade length 16 as expected (Fig. 5B ). We crossed dILP2-Gal4 to UAS-RNAi lines that knocked down 17 individual candidate miR-7 target genes, and measured blade length of affected 18 animals. Of the RNAi lines tested, one resulted in a significant decrease in blade length 19 comparable to miR-7 overexpression (Fig. 5B ). The RNAi line knocked down capping 20 protein alpha (cpa), a gene that encodes F-actin-capping protein subunit alpha. CPA 21 binds the barbed ends of actin filaments to block their assembly and disassembly 50 . 22
Unlike other capping proteins, CPA does not sever F actin. Although CPA is not known 23 to regulate insulin, the actin cytoskeleton is a known regulator of insulin secretion, and 1 disrupting other actin capping proteins has been shown to cause changes in insulin 2 secretion 51,52 . 3 4 There are two predicted miR-7 binding sites in the cpa 3'UTR. Site 1 has an 5 8mer seed sequence and shows strong potential binding to miR-7 (Fig. 5C ). Site 2 has 6 an offset 6mer seed sequence, which is not predicted to bind as strongly, though the 7 site has 3' compensatory pairing (Fig. 5C ). To verify that cpa is a direct target of miR-7, 8 we fused the cpa 3'UTR to a firefly luciferase reporter gene (Fig. 5D ). We also 9 generated reporters with base mutations in the seeds of site 1 only, site 2 only, or both 10 sites. We then transfected these reporters into Drosophila S2 cells, along with a Renilla 11 luciferase control reporter, and miR-7 expression constructs. Mutation of either site 1 or 12 site 2 resulted in a 1.5 fold derepression of firefly luciferase expression ( Fig. 5E) . 13
Mutation of both sites resulted in greater derepression, suggesting that the sites 14 function additively to inhibit gene expression ( Fig. 5E ). Taken together, these results 15 demonstrate that the sites can directly mediate miR-7 regulation of cpa transcripts. 16
17
If miR-7 acts through cpa to regulate IPC function, we predicted that RNAi of cpa 18 should phenocopy the effects seen with miR-7 overexpression in IPCs. Therefore, we 19 tested cpa RNAi animals for the other phenotypes observed with miR-7 overexpression. 20
First, we quantified dILP2 transcript levels in IPCs of RNAi animals and found that the 21 cpa RNAi line showed no change in dILP2 mRNA levels (Fig. 5F ). This result suggests 22 that CPA is not involved in production of dILP2 mRNA. However, when dILP2HF 23 peptide levels were quantified in the brains of cpa RNAi animals, there was an increase 1 in stored brain dILP2HF that was indistinguishable from miR-7 overexpression (Fig.  2   5G) . Measurement of circulating dILP2HF showed that cpa RNAi decreased circulating 3 dILP2HF to a degree indistinguishable from miR-7 overexpression (Fig. 5H) . From 4 these experiments we conclude that CPA is required to stimulate the release of dILP2 5 from IPCs. The mature miR-7 RNA has perfectly identical sequence conservation between 10
Drosophila and mammals (Fig. 1A) . Our findings indicate that miR-7 regulates dILP2 11 release in Drosophila IPCs, just as miR-7 regulates insulin secretion in mouse β-cells 28 . 12
This led us to question whether the miR-7 regulation of capping protein alpha 13 expression is similarly conserved in mammals. TargetScan, Pictar, and PITA were used 14 to predict miR-7 target genes in the human genome. Using the same search parameters 15 and stringency as the Drosophila search, we found 571 human genes that were 16 predicted targets. We then determined whether each Drosophila and human candidate 17 gene had an ortholog in the other species, and cross-referenced the two lists to find 18 orthologs in both species that are predicted miR-7 targets. Of the 571 candidates in 19 humans and 97 candidates in Drosophila, only 10 pairs of candidates were orthologous 20 to one another. Interestingly, cpa and its human ortholog CAPZA1 were the top 21 candidates, in that all algorithms predicted cpa and CAPZA1 to be miR-7 targets. There 22 is one predicted miR-7 binding site in human CAPZA1 (Fig. 6A) . The mouse Capza1 1 gene also has a predicted miR-7 binding site (Fig. 6A) . 2 3
To determine whether miR-7 regulates capping protein alpha expression in 4 mammalian pancreatic β-cells, we turned to data from mouse experiments 28 . Both 5 humans and mice contain three paralogous genes encoding miR-7 isoforms. The major 6 miR-7 paralogs are identical in sequence between the two species (Fig. 1A) , and they 7 are predicted regulators of capping protein alpha homologs in both mouse (Capza1) 8 and human (CAPZA1) (Fig. 6A ). Therefore, we analyzed a published dataset of 9 genome-wide transcript levels from mouse β-cells 28 . This dataset contained 10 transcriptomics from wildtype β-cells, as well as β-cells in which mir-7 paralogs were 11 either knocked out or overexpressed. We focused our attention on Capza1 mRNA 12 levels that were quantitated in these samples. Strikingly, there was an increase in 13
Capza1 mRNA levels in mir-7a-2 knockout β-cells ( Fig. 6B-6D ). Conversely, there was 14 a decrease in Capza1 mRNA levels when any one of the three miR-7 paralogs was 15 overexpressed in β-cells ( Fig. 6B-6D ). This result indicates that mouse Capza1 is 16
repressed by miR-7 in pancreatic β-cells. Of the thousands of miRNAs in the human genome, very few show as high a 21
degree of evolutionary sequence conservation as miR-7 33 . This has led us to question 22 whether miR-7's sequence conservation is coupled to a conserved biological function. In 23 mouse β-cells, miR-7 inhibits glucose-stimulated insulin secretion 28 . We have found that 1 in Drosophila, miR-7 inhibits dILP2 peptide release from IPCs. Thus, miR-7 plays a 2 highly conserved role in negatively regulating insulin secretion. Drosophila miR-7 3 appears to do so by repression of CPA protein expression gene in IPCs. We have found 4 that knockdown of CPA in Drosophila IPCs interferes with secretion of dILP2 peptide 5 into hemolymph. CPA binds to the barbed ends of actin filaments to inhibit additional 6 polymerization or depolymerization 50 . Dynamic actin filament polymerization is known to 7 be important for proper insulin secretion 51,52 . Mouse cell lines that have a mutation in 8 the actin-binding protein gelsolin are unable to undergo glucose-mediated insulin 9 exocytosis due to their inability to depolymerize their cytoskeleton 51 . It remains unclear 10 exactly how loss of CPA disrupts the secretory process, and whether it occurs via actin 11 capping. Perhaps CPA stimulates dILP2 secretion by similar mechanisms, and miR-7 12 attenuates CPA abundance, thereby down-regulating dILP2 secretion. 13
14
This then raises the question as to whether miR-7 attenuation of mouse Capza1 15 gene expression also downregulates insulin secretion in pancreatic β-cells. Although 16 SNCA was found to mediate the effects of mouse miR-7a-2 on insulin secretion 28 , it 17 appears that mouse miR-7a-2 also directly represses Capza1 expression. If Capza1 18 plays a role in insulin secretion, then the conserved regulatory interaction between miR-19 7 and CPA/Capza1 is likely coupled to the conserved endocrine control of glucose 20 metabolism. 21
22
In the marine annelid Platynereis, miR-7 is expressed in neurosecretory cells that 1 release the vasotocin and FMRF-amide neuropeptides 53 . Although FMRF-amides are 2 exclusive to invertebrates, vasotocin is homologous to oxytocin and vasopressin in 3 mammals, and vasotocin is secreted from the pituitary gland in non-mammalian 4 vertebrates. Strikingly, the regions of the vertebrate brain that secrete these 5 neuropeptides, the hypothalamus and pituitary, are also regions where the miR-7 gene 6 family is highly expressed 54 . miR-7a2 was recently shown to regulate hormone 7 secretion in the mouse pituitary 55 . Possibly, an ancient role for miR-7 was to regulate 8 neuropeptide release in the bilaterian ancestor, and this role has been retained during 9 the evolution of all animals. Interestingly, the actin binding protein profilin seems to be 10 regulated by miR-7 in both pancreatic islet cells and in the pituitary 55 suggesting that 11 perhaps miR-7 has retained a role in regulating the cytoskeleton across organisms and 12 in different endocrine cell types. 13
14
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